Search research articles
Contact Us
Filters
Showing results (1-10 of 48) with videos related to
Page
of 5
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 18, 2010
The alpha-camera: a quantitative digital autoradiography technique using a charge-coupled device for ex vivo high-resolution bioimaging of alpha-particles
Tom Bäck, Lars Jacobsson
Nuclear Medicine and Biology
|
February 8, 2026
Spontaneous association of different forms of non-conjugated astatine-211 to serum albumin
Emma Aneheim, Sture Lindegren, Holger Jensen, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 28, 2023
Pretargeted Alpha Therapy of Disseminated Cancer Combining Click Chemistry and Astatine-211
Chiara Timperanza, Holger Jensen, Tom Bäck, et al.
Plos One
|
September 24, 2024
A proposed production method for astatinated (At-211) Trastuzumab for use in a Phase I clinical trial
Emma Aneheim, Tom Bäck, Holger Jensen, et al.
Bioconjugate Chemistry
|
May 16, 2002
Synthesis and biodistribution of 211At-labeled, biotinylated, and charge-modified poly-L-lysine: evaluation for use as an effector molecule in pretargeted intraperitoneal tumor therapy
Sture Lindegren, Håkan Andersson, Lars Jacobsson, et al.
EJNMMI Radiopharmacy and Chemistry
|
May 22, 2024
In vitro and in vivo evaluation of a tetrazine-conjugated poly-L-lysine effector molecule labeled with astatine-211
Chiara Timperanza, Holger Jensen, Ellinor Hansson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 16, 2008
Direct procedure for the production of 211At-labeled antibodies with an epsilon-lysyl-3-(trimethylstannyl)benzamide immunoconjugate
Sture Lindegren, Sofia Frost, Tom Bäck, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 16, 2016
Biokinetic Modeling and Dosimetry for Optimizing Intraperitoneal Radioimmunotherapy of Ovarian Cancer Microtumors
Stig Palm, Tom Bäck, Börje Haraldsson, et al.
BMC Cancer
|
May 4, 2017
Immunohistochemical evaluation of epithelial ovarian carcinomas identifies three different expression patterns of the MX35 antigen, NaPi2b
Kristina Levan, Matin Mehryar, Constantina Mateoiu, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
February 21, 2020
Realizing Clinical Trials with Astatine-211: The Chemistry Infrastructure
Sture Lindegren, Per Albertsson, Tom Bäck, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 48) with videos related to
Sort By:
Page
of 5
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 18, 2010
The alpha-camera: a quantitative digital autoradiography technique using a charge-coupled device for ex vivo high-resolution bioimaging of alpha-particles
Tom Bäck, Lars Jacobsson
Nuclear Medicine and Biology
|
February 8, 2026
Spontaneous association of different forms of non-conjugated astatine-211 to serum albumin
Emma Aneheim, Sture Lindegren, Holger Jensen, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 28, 2023
Pretargeted Alpha Therapy of Disseminated Cancer Combining Click Chemistry and Astatine-211
Chiara Timperanza, Holger Jensen, Tom Bäck, et al.
Plos One
|
September 24, 2024
A proposed production method for astatinated (At-211) Trastuzumab for use in a Phase I clinical trial
Emma Aneheim, Tom Bäck, Holger Jensen, et al.
Bioconjugate Chemistry
|
May 16, 2002
Synthesis and biodistribution of 211At-labeled, biotinylated, and charge-modified poly-L-lysine: evaluation for use as an effector molecule in pretargeted intraperitoneal tumor therapy
Sture Lindegren, Håkan Andersson, Lars Jacobsson, et al.
EJNMMI Radiopharmacy and Chemistry
|
May 22, 2024
In vitro and in vivo evaluation of a tetrazine-conjugated poly-L-lysine effector molecule labeled with astatine-211
Chiara Timperanza, Holger Jensen, Ellinor Hansson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 16, 2008
Direct procedure for the production of 211At-labeled antibodies with an epsilon-lysyl-3-(trimethylstannyl)benzamide immunoconjugate
Sture Lindegren, Sofia Frost, Tom Bäck, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 16, 2016
Biokinetic Modeling and Dosimetry for Optimizing Intraperitoneal Radioimmunotherapy of Ovarian Cancer Microtumors
Stig Palm, Tom Bäck, Börje Haraldsson, et al.
BMC Cancer
|
May 4, 2017
Immunohistochemical evaluation of epithelial ovarian carcinomas identifies three different expression patterns of the MX35 antigen, NaPi2b
Kristina Levan, Matin Mehryar, Constantina Mateoiu, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
February 21, 2020
Realizing Clinical Trials with Astatine-211: The Chemistry Infrastructure
Sture Lindegren, Per Albertsson, Tom Bäck, et al.
Page
of 5